多病共存与功能受限对心力衰竭患者生活质量的影响:多中心研究
该多中心研究纳入3020例心力衰竭患者,按多病共存和功能受限分为四组,发现仅有功能受限的患者在焦虑、抑郁、疲劳、睡眠、疼痛及社交活动方面的健康相关生活质量与同时存在多病共存和功能受限者相似,均显著差于两者均无者。
要点
- 仅功能受限的心衰患者,其焦虑、抑郁、疲劳、睡眠、疼痛及社交困难风险与多病共存合并功能受限者相似。
- 功能受限与社交活动困难关联最强(OR 9.40),其次为疼痛(OR 6.73)和疲劳(OR 4.19)。
- 评估心衰患者生活质量时,应重视功能状态而非仅关注多病共存。
核心结论
- 仅存在功能受限的心衰患者,其健康相关生活质量差的程度与同时存在多病共存和功能受限者相似,凸显身体功能对心衰患者健康的重要性。
研究设计与样本
- 多中心调查研究,纳入美国四家机构2013年1月1日至2018年2月1日期间≥30岁、有至少两个心衰诊断代码且至少一种心衰相关处方药的患者,邮寄调查测量功能状态(ADLs)和健康相关生活质量(PROMIS-29)。
- 共3330例患者返回调查(应答率31%),其中3020例完成目标问题并纳入分析;患者45%为女性,平均年龄73岁(标准差12)。
- 多病共存定义为≥2种非心血管合并症;功能受限定义为8项ADLs中至少1项受限;按两者有无分为四组,将PROMIS-29子量表得分按中位数二分类,计算四组的比值比。
主要发现
- 29%的患者既无多病共存也无功能受限,24%仅有多病共存,22%仅有功能受限,25%两者均有。
- 与两者均无者相比,仅有功能受限者焦虑风险升高(OR 3.44,95%CI 2.66-4.45),抑郁风险升高(OR 3.11,95%CI 2.39-4.06),疲劳风险升高(OR 4.19,95%CI 3.25-5.40)。
- 仅有功能受限者睡眠更差(OR 2.14,95%CI 1.69-2.72),疼痛风险升高(OR 6.73,95%CI 5.15-8.78),社交活动困难风险升高(OR 9.40,95%CI 7.19-12.28)。
- 同时存在多病共存和功能受限者的结果与仅有功能受限者相似。
关键数值与推荐
- 多病共存定义为≥2种非心血管合并症;功能受限定义为8项ADLs中至少1项受限。
- PROMIS-29子量表得分按中位数二分类,计算比值比(OR)及95%置信区间(CI)。
临床怎么用
- 在心衰患者管理中,应常规评估功能状态(ADLs),功能受限可作为生活质量恶化的重要警示信号。
- 对于仅有功能受限而无多病共存的心衰患者,也应积极干预焦虑、抑郁、疲劳、睡眠、疼痛及社交困难。
局限性
- 应答率31%,可能存在无应答偏倚。
- 研究为横断面调查,无法推断因果关系。
- 多病共存仅定义为非心血管合并症,未纳入心血管合并症。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Multimorbidity and functional limitation are associated with poor outcomes in heart failure (HF). However, the individual and combined effect of these on health-related quality of life in patients with HF is not well understood. METHODS: Patients aged ≥30 years with two or more HF diagnostic codes and one or more HF-related prescription drugs from four U.S. institutions were mailed a survey to measure patient-centric factors including functional status (activities of daily living [ADLs]) and health-related quality of life (PROMIS-29 Health Profile). Patients with HF from January 1, 2013 to February 1, 2018 were included. Multimorbidity was defined as ≥2 non-cardiovascular comorbidities; functional limitation as any limitation in at least one of eight ADLs. Patients were categorized into four groups by multimorbidity (Yes/No) and functional limitation (Yes/No). We dichotomized the PROMIS-29 sub-scale scores at the median and calculated odd ratios for the four multimorbidity/functional limitation groups. RESULTS: A total of 3330 patients with HF returned the survey (response rate 31%); 3020 completed the questions of interest and were retained. Among these patients (45% female; mean age 73 [standard deviation: 12] years), 29% had neither multimorbidity nor functional limitation, 24% had multimorbidity only, 22% had functional limitation only, and 25% had both. After adjustment, having functional limitation only was associated with higher anxiety (odds ratio [OR]: 3.44, 95% confidence interval [CI]: 2.66-4.45), depression (OR: 3.11, 95% CI: 2.39-4.06), and fatigue (OR: 4.19, 95% CI: 3.25-5.40); worse sleep (OR: 2.14, 95% CI: 1.69-2.72) and pain (OR: 6.73, 95% CI: 5.15-8.78); and greater difficulty with social activities (OR: 9.40, 95% CI: 7.19-12.28) compared with having neither. Results were similar for having both multimorbidity and functional limitation. CONCLUSION: Patients with only functional limitation have similar poor health-related quality of life scores as those with both multimorbidity and functional limitation, underscoring the important role that physical functioning plays in the well-being of patients with HF.
引用
- Manemann SM, Hade EM, Haller IV, et al. The impact of multimorbidity and functional limitation on quality of life in patients with heart failure: A multi-site study. J Am Geriatr Soc. 2024. PMID: 38634747. doi:10.1111/jgs.18924
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。